Ken Griffin Lixte Biotechnology Hldgs Inc Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lixte Biotechnology Hldgs Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 27,332 shares of LIXTW stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,332
Previous 28,141 2.87%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
N/A
-809 Reduced 2.87%
27,332 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-3,981 Reduced 12.39%
28,141 $0
Q2 2024

Aug 14, 2024
BUY
N/A
32,122 New
32,122 $0
Q1 2023

May 15, 2023
BUY
N/A
11,067 New
11,067 $0

Others Institutions Holding LIXTW

# of Institutions
3
Shares Held
49.9K
Call Options Held
0
Put Options Held
0
View Full List

About LIXTE BIOTECHNOLOGY HLDGS INC

LIXTW Quotes by TradingView
  • Ticker LIXTW
More about LIXTW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email